B
20.23
-0.56 (-2.69%)
前收盘价格 | 20.79 |
收盘价格 | 20.93 |
成交量 | 274,642 |
平均成交量 (3个月) | 383,680 |
市值 | 957,769,088 |
预期市盈率 (P/E Forward) | 250.00 |
价格/销量 (P/S) | 10.55 |
股市价格/股市净资产 (P/B) | 3.89 |
52周波幅 | |
利润日期 | 6 Aug 2024 - 12 Aug 2024 |
营业毛利率 | -31.32% |
营业利益率 (TTM) | -5.10% |
稀释每股收益 (EPS TTM) | -1.11 |
季度收入增长率 (YOY) | 29.70% |
总债务/股东权益 (D/E MRQ) | 12.06% |
流动比率 (MRQ) | 2.78 |
营业现金流 (OCF TTM) | 9.10 M |
杠杆自由现金流 (LFCF TTM) | 10.14 M |
资产报酬率 (ROA TTM) | -5.97% |
股东权益报酬率 (ROE TTM) | -15.04% |
市场趋势
短期 | 中期 | ||
行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
Medical Instruments & Supplies (全球的) | 混合的 | 混合的 | |
股票 | BioLife Solutions, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
2.6
分析师共识 | 3.0 |
内部交易活动 | NA |
价格波动 | 1.0 |
技术平均移动指标 | 2.5 |
技术振荡指标 | 4.0 |
平均 | 2.63 |
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
部门 | Healthcare |
行业 | Medical Instruments & Supplies |
投资方式 | Small Core |
内部持股比例 | 1.94% |
机构持股比例 | 99.74% |
52周波幅 | ||
目标价格波幅 | ||
高 | 33.00 (Keybanc, 63.12%) | 购买 |
中 | 31.00 (53.24%) | |
低 | 27.00 (HC Wainwright & Co., 33.47%) | 购买 |
平均值 | 30.60 (51.26%) | |
总计 | 5 购买 | |
平均价格@调整类型 | 24.30 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Benchmark | 19 Dec 2024 | 30.00 (48.29%) | 购买 | 26.11 |
Keybanc | 13 Dec 2024 | 33.00 (63.12%) | 购买 | 26.70 |
HC Wainwright & Co. | 18 Nov 2024 | 27.00 (33.47%) | 购买 | 20.47 |
30 Sep 2024 | 29.00 (43.35%) | 购买 | 25.04 | |
Craig-Hallum | 13 Nov 2024 | 32.00 (58.18%) | 购买 | 24.11 |
TD Cowen | 13 Nov 2024 | 31.00 (53.24%) | 购买 | 24.11 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合